Session Introduction | |||||
Tue4 Oct11:05am(5 mins)
|
![]() |
Anna Morgan |
![]() |
Simon Pitchford | |
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
The burden of unmet needs in COPD | |||||
Tue4 Oct11:10am(30 mins)
|
![]() |
Wisia Wedzicha | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Novel drug targets in COPD | |||||
Tue4 Oct11:40am(30 mins)
|
![]() |
Ian Adcock | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
New perspectives for modelling inflammatory diseases using patient-derived organoids | |||||
Tue4 Oct12:10pm(5 mins)
|
![]() |
Sylvia F. Boj | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Use of Imaging for preclinical evaluation of drugs for the treatment of COPD | |||||
Tue4 Oct12:15pm(30 mins)
|
![]() |
Anna Morgan | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Preclinical translational models for investigating drugs for the treatment of COPD | |||||
Tue4 Oct02:00pm(30 mins)
|
![]() |
Simon Pitchford | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Use of human tissues to investigate drugs for the treatment of COPD | |||||
Tue4 Oct02:30pm(30 mins)
|
![]() |
Luigino Calzetta | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Early experimental medicine studies for investigating new drugs for COPD | |||||
Tue4 Oct03:45pm(30 mins)
|
![]() |
Dave Singh | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Methods to tackle novel molecular targets involved in inflammatory disease | |||||
Tue4 Oct04:15pm(15 mins)
|
![]() |
Mark Abbott | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Publishing in the British Journal of Pharmacology | |||||
Tue4 Oct04:30pm(30 mins)
|
![]() |
Charles Whalley | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Session Introduction | |||||
Wed5 Oct11:00am(5 mins)
|
![]() |
Martin Swarbrick |
![]() |
Mary Wheldon | |
![]() |
A Ganesan |
![]() |
Becky Garton | ||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Platforms for the generation and high-throughput screening of cyclic peptide libraries. | |||||
Wed5 Oct11:05am(30 mins)
|
![]() |
Ali Tavassoli | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Ligand discovery in dark chemical space leading to biological insights | |||||
Wed5 Oct12:05pm(30 mins)
|
![]() |
John Irwin | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Oxford Nanopore Technologies - a look into the complete genome | |||||
Wed5 Oct12:35pm(15 mins)
|
![]() |
Daniel Fordham | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Discovery of the clinical candidate, ASTX029, a dual mechanism ERK inhibitor | |||||
Wed5 Oct02:00pm(30 mins)
|
![]() |
Nicola Wallis | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
TargetMol:Targets small molecules in drug discovery | |||||
Wed5 Oct02:35pm(5 mins)
|
![]() |
Phoebe Feng | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
The Discovery and Clinical Efficacy of Sisunatovir | |||||
Wed5 Oct02:40pm(30 mins)
|
![]() |
Stuart Cockerill | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Simplifying Synthesis with Electricity | |||||
Wed5 Oct04:15pm(45 mins)
|
![]() |
Phil Baran | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |